GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Response Oncology Inc (GREY:ROIX) » Definitions » Change In Receivables

Response Oncology (Response Oncology) Change In Receivables : $9.9 Mil (TTM As of Mar. 2002)


View and export this data going back to 1989. Start your Free Trial

What is Response Oncology Change In Receivables?

Response Oncology's change in receivables for the quarter that ended in Mar. 2002 was $2.9 Mil. It means Response Oncology's Accounts Receivable declined by $2.9 Mil from Dec. 2001 to Mar. 2002 .

Response Oncology's change in receivables for the fiscal year that ended in Dec. 2001 was $10.0 Mil. It means Response Oncology's Accounts Receivable declined by $10.0 Mil from Dec. 2000 to Dec. 2001 .

Response Oncology's Accounts Receivable for the quarter that ended in Mar. 2002 was $3.5 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Response Oncology's Days Sales Outstanding for the three months ended in Mar. 2002 was 13.83.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Response Oncology's liquidation value for the three months ended in Mar. 2002 was $-31.8 Mil.


Response Oncology Change In Receivables Historical Data

The historical data trend for Response Oncology's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Response Oncology Change In Receivables Chart

Response Oncology Annual Data
Trend Dec92 Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.10 -8.90 4.10 4.16 9.95

Response Oncology Quarterly Data
Jun97 Sep97 Dec97 Mar98 Jun98 Sep98 Dec98 Mar99 Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.87 -3.36 0.35 10.10 2.86

Response Oncology Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2002 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Response Oncology  (GREY:ROIX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Response Oncology's Days Sales Outstanding for the quarter that ended in Mar. 2002 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3.455/22.79*91
=13.83

2. In Ben Graham's calculation of liquidation value, Response Oncology's accounts receivable are only considered to be worth 75% of book value:

Response Oncology's liquidation value for the quarter that ended in Mar. 2002 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=9.008-44.66+0.75 * 3.455+0.5 * 2.496
=-31.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Response Oncology Change In Receivables Related Terms

Thank you for viewing the detailed overview of Response Oncology's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Response Oncology (Response Oncology) Business Description

Traded in Other Exchanges
N/A
Address
1775 Moriah Woods Boulevard, Memphis, TN, USA, 38117
Website
Response Oncology Inc provides cancer treatments and related services on an outpatient basis.

Response Oncology (Response Oncology) Headlines

No Headlines